Evaluating the transdermal permeability of chemicals

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 25-55

  Vecchia, Brent E ^a,b   Bunge, Annette L ^a  

^a Department of Geology and Geological Engineering   (United States)

^b Blakely Sokoloff Taylor and Zafman LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85053738037     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (48)

1. GL Flynn. Physicochemical determinants of skin absorption. In: TR Ger-rity, CJ Henry, eds. Principles of Route-to-Route Extrapolation for Risk Assessment. New York: Elsevier, 1990, pp 93-127.
2. GB Kasting, RL Smith, BD Anderson. Prodrugs for dermal delivery: solubility, molecular size, and functional group effects. In: KB Sloan, ed. Prodrugs: Topical and Ocular Drug Delivery. New York: Marcel Dekker, 1992, pp 117-161.
3. MH Abraham, HS Chadha, RC Mitchell. The factors that influence skin penetration of solutes. J Pharm Pharmacol 47:8-16, 1995.
4. BE Vecchia. Estimating the dermally absorbed dose from chemical exposure: data analysis, parameter estimation, and sensitivity to parameter uncertainties. M.S. thesis, Colorado School of Mines, Golden, CO, 1997.
5. RL Bronaugh, CN Barton. Prediction of human percutaneous absorption with physiochemical data. In: RG Wang and HI Maibach, eds. Health Risk Assessment through Dermal and Inhalation Exposure and Absorption of Toxicants. Boca Raton, FL: CRC Press, 1991.
6. SL Brown, JE Rossi. A simple method for estimating dermal absorption of chemicals in water. Chemosphere 19:1989-2001, 1989.
7. RJ Scheuplein, IH Blank. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol 60:286-296, 1973.
8. MS Roberts, RA Anderson, J Swarbrick. Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol 29:677-683, 1977.
9. AS Michaels, SK Chandrasekaran, JE Shaw. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J 21:985-996, 1975.
10. RL Cleek, AL Bunge. A new method for estimating dermal absorption from chemical exposure. 1. General approach. Pharm Res 10:497-506, 1993.
11. N EI Tayar, RS Tsai, B Testa, PA Carrupt, C Hansch, A Leo. Percutaneous penetration of drugs: a quantitative structure-permeability relationship study. J Pharm Sci 80:744-749, 1991.
12. BD Anderson, WI Higuchi, PV Raykar. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 5:566-573, 1988.
13. US EPA. Dermal exposure assessment: principles and applications, EPA/600/8-91/011B, Exposure Assessment Group, Office of Health and Environmental Assessment, Office of Research and Development, Washington, DC, 1992.
14. TE McKone, RA Howd. Estimating dermal uptake of nonionic organic chemicals from water and soil. I. Unified fugacity-based models for risk assessments. Risk Analysis 12:543-557, 1992.
15. Y Morimoto, T Hatanaka, K Sugibayashi, H Omiya. Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 44:634-639, 1992.
16. RO Potts, RH Guy. Predicting skin permeability. Pharm Res 9:663-669, 1992.
17. RJ Scheuplein. Molecular structure and diffusional processes across intact epidermis. Contract No. DA18-108-AMC-148(A), U.S. Army Chemical Research and Development Laboratories, Edgewood Arsenal, MD, 1967.
18. O Siddiqui, MS Roberts, AE Polack. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharm 17:405-424, 1989.
19. V Fiserova-Bergerova, JT Pierce, PO Droz. Dermal absorption potential of industrial chemicals: criteria for skin notation. Am J Ind Med 17:617-635, 1990.
20. A Wilschut, WF ten Berge, PJ Robinson, TE McKone. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 30:1275-1296, 1995.
21. B Berner, ER Cooper. Models of skin permeability. In: AF Kydonieus, B Berner, eds. Transdermal Delivery of Drugs. Boca Raton, FL: CRC Press, 1987, pp 41-56.
22. AL Bunge. Re: “Dermal absorption potential of industrial chemicals: criteria for skin notation.” Am J Ind Med 34:89-90, 1998.
23. V Fiserova-Bergerova. Re: Response to Bunge’s letter to the editor. Am J Ind Med 34:91, 1998.
24. DW Osborne. Computation methods for predicting skin permeability in pharmaceutical manufacturing. Technical update, Upjohn Co., Kalamazoo, MI, 1986.
25. AL Bunge, JN McDougal. Dermal uptake. In: S Olin, ed. Exposure to Contaminants in Drinking Water: Estimating Uptake Through the Skin and by Inhalation. Boca Raton, FL: CRC Press, 1999, pp 137-181.
26. C Hansch, A Leo, D Hoekman. Exploring QSAR: Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society, 1995.
27. PCModel. Ver. 4.2, Daylight Chemical Information Systems, Inc., Mission Viejo, CA, 1995.
28. SPARC (SPARC performs automated reasoning in chemistry): an expert system for estimating physical and chemical reactivity. Ver. Windows Prototype Version 1.1, US EPA (Ecosystem Research Division) and University of Georgia, Athens, GA, 1995.
29. a’s. QSARDI 14:348-355, 1995.
30. T Dutkiewicz, H Tyras. A study of the skin absorption of ethylbenzene in man. Br J Ind Med 24:330-332, 1967.
31. T Dutkiewicz, H Tyras. Skin absorption of toluene, styrene, and xylene by man. Br J Ind Med 25:243, 1968.
32. RJ Scheuplein, IH Blank. Permeability of the skin. Physiol Rev 51:702-747, 1971.
33. J Hadgraft, G Ridout. Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int J Pharm 39:149-156, 1987.
34. MS Roberts, RA Anderson. The percutaneous absorption of phenolic compounds: the effect of vehicles on the penetration of phenol. J Pharm Pharmacol 27:599-605, 1975.
35. ZT Chowhan, R Pritchard. Effect of surfactants on percutaneous absorption of naproxen. I. Comparisons of rabbit, rat, and human excised skin. J Pharm Sci 67:1272-1274, 1978.
36. LM Jolicoeur, MR Nassiri, C Shipman, HK Choi, GL Flynn. Etorphine is an opiate analgesic physicochemically suited to transdermal delivery. Pharm Res 9:963-965, 1992.
37. BD Anderson. Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, personal communication, 1995.
38. KD Peck. Ph.D. thesis, University of Utah, Salt Lake City, 1996.
39. SD Roy, GL Flynn. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 6:825-832, 1989.
40. GE Parry, AL Bunge, GD Silcox, LK Pershing, DW Pershing. Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling. Pharm Res 7:230-236, 1990.
41. BW Barry, SM Harrison, PH Dugard. Vapour and liquid diffusion of model penetrants through human skin; correlation with thermodynamic activity. J Pharm Pharmacol 37:226-236, 1985.
42. P Singh, MS Roberts. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther 268:144-151, 1994.
43. GB Kasting, RL Smith, ER Cooper. Effect of lipid solubility and molecular size on percutaneous absorption. In B Shroot, H Schaefer, eds. Skin Pharmacokinetics. Basel: Karger, 1987, pp 138-153.
44. T Itoh, J Xia, R Magavi, T Nishihata, JH Rytting. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm Res 7:1042-1047, 1990.
45. JMP Statistical Discovery Software. Ver. 3.1. Cary, North Carolina; SAS Institute, 1995.
46. RJ Scheuplein, IH Blank, GJ Brauner, DJ MacFarlane. Percutaneous absorption of steroids. J Invest Dermatol 52:63-70, 1969.
47. MS Roberts. Percutaneous absorption of phenolic compounds. Ph.D. thesis, University of Sydney, Sydney, Australia, 1976.
48. RL Bronaugh, ER Congdon, RJ Scheuplein. The effect of cosmetic vehicles on the penetration of A-nitrosodiethanolamine through excised human skin. J Invest Dermatol 76:94-96, 1981.